Blueprint Medicines Corp - Company Profile
Powered by 
All the data and insights you need on Blueprint Medicines Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Blueprint Medicines Corp Strategy Report
- Understand Blueprint Medicines Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Blueprint Medicines Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Jun 2022 | Royalty Pharma to Acquire Royalties of GAVRETO from Blueprint Medicines | Asset Transaction |
Royalty Pharma Plc
|
Blueprint Medicines Corp |
| 26 Feb 2022 | Blueprint Medicines and Proteovant Therapeutics Enter into Collaboration | Partnership | - |
Blueprint Medicines Corp
Proteovant Therapeutics Inc
|
| 27 Nov 2021 | Blueprint Medicines Acquires Lengo Therapeutics | Acquisition |
Blueprint Medicines Corp
|
Lengo Therapeutics Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer